Skip to main navigation Skip to search Skip to main content

Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression

  • W. A. Paxton
  • , S. Kang

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

It is now well established that an array of CC and CXC chemokine receptors, in association with the CD4 molecule, can interact with the HIV-1 gp120 protein to facilitate viral fusion. A 32bp deletion in the CC chemokine receptor CCR5, the major M-tropic viral co-receptor, provides considerable protection against HIV-1 transmission and has been associated with a delay in disease progression. The effects of the Delta32 allele appear to be mediated through the phenotype of CCR5 expression as opposed to genotype. Here we discuss the potential effects that the Delta32 allele and other polymorphisms in the chemokine receptor repertoire may have on both HIV-1 transmission and disease progression
Original languageEnglish
Pages (from-to)187-194
JournalSeminars in immunology
Volume10
Issue number3
DOIs
Publication statusPublished - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 5 - Gender Equality
    SDG 5 Gender Equality

Fingerprint

Dive into the research topics of 'Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression'. Together they form a unique fingerprint.

Cite this